Can intravenous potassium be administered through an intraosseous (IO) line?

Yes, Potassium Can Be Administered Through an Intraosseous Line

All intravenous medications, including potassium, can be safely administered through an intraosseous (IO) line with comparable onset of action and drug levels to venous administration. 1

Evidence Supporting IO Administration of Potassium

The American Heart Association's 2010 Pediatric Advanced Life Support Guidelines explicitly state that "All intravenous medications can be administered intraosseously, including epinephrine, adenosine, fluids, blood products, and catecholamines" with onset of action and drug levels comparable to venous administration. 1 While potassium is not specifically listed in this excerpt, the guideline's use of "all intravenous medications" provides clear support for IO potassium administration. 1

Pharmacokinetic Equivalence

• IO access provides drug delivery similar to peripheral venous access at comparable doses, with access to a noncollapsible venous plexus that enables reliable medication administration. 2

• Research demonstrates that most drugs administered intravenously can be given intraosseously in equivalent dosages with the same effects. 3

• Animal studies have confirmed that the IO route is comparable in effect to central and peripheral IV routes for emergency medications, with equivalent magnitudes of peak effect and equal or longer durations of action. 4

Practical Considerations for IO Potassium Administration

Administration Technique

• Use manual pressure or an infusion pump to administer viscous drugs or rapid fluid boluses through the IO line. 1

• Follow each medication with a saline flush to promote entry into the central circulation. 1

• Standard IV potassium administration guidelines apply: rates should not exceed 10 mEq/hour in concentrations less than 30 mEq/liter when serum potassium is greater than 2.5 mEq/liter. 5

Clinical Context

• IO access is particularly valuable when IV access cannot be rapidly obtained during emergencies, with insertion times typically between 1-2 minutes. 3, 6

• The tibia and humerus are preferred IO insertion sites, with the tibial site located 2 cm distal to the tibial tuberosity and 1 cm medial to the tibial plateau. 7

• IO devices should be removed as soon as suitable IV access is achieved, ideally within 24 hours of placement to minimize complications. 7

Important Caveats

Flow Rate Limitations

• Flow rates through IO access devices are lower than large-bore peripheral IV catheters, but fluid resuscitation is possible with pressure bag infusion systems. 3

• For potassium infusions requiring precise rate control, this may necessitate use of an infusion pump rather than gravity flow. 1

Monitoring Requirements

• Acid-base analysis is inaccurate after sodium bicarbonate administration via the IO cannula, though this does not affect potassium administration. 1

• Standard potassium monitoring protocols apply regardless of administration route. 5

Complications

• Extravasation occurs in approximately 12% of IO cases and is the most common adverse effect. 6

• Rare but serious complications include compartment syndrome, osteomyelitis, and tibial fracture. 7, 6

• These complication rates remain less than 1% overall when proper technique is used. 8

Route Selection Algorithm

For emergency potassium replacement:

1. Attempt peripheral IV access first if feasible and not time-consuming 1
2. If peripheral IV cannot be rapidly obtained, establish IO access 1, 2
3. Administer potassium at standard IV dosing with appropriate rate control 5
4. Transition to IV access within 24 hours when clinically stable 7